USD 0.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -16.89 Million USD | 641.2% |
2022 | -183.99 Million USD | 88.43% |
2021 | -305.6 Million USD | -1630.64% |
2020 | -1.6 Million USD | -68.44% |
2019 | -953.44 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -4.99 Million USD | 37.83% |
2023 Q3 | 5.63 Million USD | 18.55% |
2023 Q4 | 881 Thousand USD | -84.37% |
2023 FY | - USD | 641.2% |
2023 Q2 | 4.75 Million USD | -22.5% |
2023 Q1 | 6.13 Million USD | 4189.51% |
2022 Q4 | 143 Thousand USD | 104.22% |
2022 FY | - USD | 88.43% |
2022 Q3 | -3.38 Million USD | -225.21% |
2022 Q2 | 2.7 Million USD | 201.73% |
2022 Q1 | -2.65 Million USD | 92.16% |
2021 FY | - USD | -1630.64% |
2021 Q4 | -33.89 Million USD | -838.84% |
2021 Q3 | 4.58 Million USD | 0.0% |
2020 FY | - USD | -68.44% |
2019 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Babylon Holdings Limited | -176.72 Million USD | 90.44% |
ETAO International Co., Ltd. | -893.88 Million USD | 98.11% |
MedAvail Holdings, Inc. | -41.76 Million USD | 59.545% |
Micron Solutions, Inc. | -308.4 Thousand USD | -5378.581% |
Motus GI Holdings, Inc. | -11.23 Million USD | -50.454% |
ThermoGenesis Holdings, Inc. | -7.74 Million USD | -118.295% |
Titan Medical Inc. | 7.51 Million USD | 324.698% |